Position in EXEL
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$2,883
+$1,125 QoQ
Shares Held
53
+29.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#704
of 751 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bay Harbor Wealth Management, LLC holds $57,046 across 24 Biotechnology names. EXEL ranks #7 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
27 | $13,411 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12 | $7,482 | |
| 3 | MRNA |
Moderna, Inc.
|
61 | $4,271 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14 | $4,214 | |
| 5 | INCY |
Incyte Corp
|
36 | $4,080 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
14 | $3,373 | |
| 7 | EXEL |
Exelixis, Inc.
This page
|
53 | $2,883 | |
| 8 | DARE |
Dare Bioscience, Inc.
|
1,358 | $2,865 |
All Filings in EXEL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,883 | 53 | Shares | Other | 2026-07-28 | |
| 2026-03-31 | $1,758 | 41 | Shares | Other | 2026-04-14 | |
| 2025-12-31 | $920 | 21 | Shares | Other | 2026-02-02 | |
| 2025-09-30 | $578 | 14 | Shares | Other | 2025-10-09 | |
| 2025-06-30 | $661 | 15 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $295 | 8 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||